Uterine cancer (also known as endometrial cancer) is the fourth most common cancer women in the U.S. are diagnosed with. It ...

Short-course vaginal cuff brachytherapy (VCB) is noninferior to standard regimens for short-term quality of life in ...

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

A 58-year-old woman mistook her womb cancer symptoms for menopause until her stomach became swollen. Diagnosed with advanced-stage womb cancer, she is ...

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

The FDA has granted breakthrough device designation to the ACR-368 OncoSignature assay for use in endometrial cancer.

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

The cancer mortality rate has significantly declined among Black individuals in the U.S. from 1991 to 2022. However, their ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.